Streptococcus pneumoniae-induced purpura fulminans in a woman with functional asplenia

Canadian Journal of Emergency Medicine

Volumn 16, Issue 4, 2014, Pages 339-342

  Wojtowicz, Jeremy M ^a   Jones, Graham Longden ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Purpura fulminans; Splenectomy; Streptococcus pneumoniae

Indexed keywords

ADULT; CASE REPORT; COMPLICATION; FEMALE; HETEROTAXY SYNDROME; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMOCOCCAL INFECTIONS; PURPURA FULMINANS; STREPTOCOCCUS PNEUMONIAE;

ADULT; FEMALE; HETEROTAXY SYNDROME; HUMANS; PNEUMOCOCCAL INFECTIONS; PURPURA FULMINANS; STREPTOCOCCUS PNEUMONIAE;

EID: 84905869059     PISSN: 14818035     EISSN: 14818043     Source Type: Journal    
DOI: 10.2310/8000.2013.130990     Document Type: Article

References (18)

1. Jakob A, Alexandrakis E, Rompel R. Purpura fulminans secondary to respiratory infection. J Dtsch Dermatol Ges 2009;7:135-8
2. Francis RB Jr. Acquired purpura fulminans. Semin Thromb Hemost 1990;16:310-25. doi:10.1055/s-2007-1002684
3. Holdsworth R, Irving A, Cushieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991;78:1031-8. doi:10.1002/bjs.1800780904
4. Bisharat N, Omari H, Lavi I, et al. Risk of infection and death among post-splenectomy patients. J Infect 2001;43: 182-6. doi:10.1053/jinf.2001.0904
5. Melles DC, de Marie S. Prevention of infections in hyposplenic and asplenic patients: an update. Neth J Med 2004;62:45-52
6. Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect 2001;7:657-60. doi:10.1046/j.1198-743x.2001.00355.x.
7. Jenks PJ, Jones E. Infections in asplenic patients. Clin Microbiol Infect 1996;1:266-72
8. Chalmers E, Cooper P, Forman K, et al. Purpura fulminans: recognition, diagnosis and management. Arch Dis Child 2011;96:1066-71. doi:10.1136/adc.2010.199919
9. Warner PM, Kagan RJ, Yakuboff KP, et al. Current management of purpura fulminans: a multicenter study. J Burn Care Rehabil 2003;24:119-26. doi:10.1097/01.BCR. 0000066789.79129.C2
10. Basem M, Corazza G. Hyposplenism: a comprehensive review. Part 1: basic concepts and causes. Hematology 2007; 12:1-13. doi:10.1080/10245330600938422
11. Price VE, Blanchette VS, Ford-Jones EL. The prevention and management of infections in children with asplenia or hyposplenism. Infect Dis Clin North Am 2007;21:697-710. doi:10.1016/j.idc.2007.07.002
12. Basem M, Thawani N, Sae-Tia S, et al. Hyposplenism: a comprehensive review. Part 2: clinical manifestations, diagnosis and management. Hematology 2007;12:89-98. doi:10.1080/10245330600938463
13. Piette WW. The differential diagnosis of purpura from a morphologic perspective. Adv Dermatol 1994;9:3-23
14. Rivers E, Nguyen B, Havstad S, et al. Early goal directed therapy in the early treatment of severe sepsis and septic shock. NEnglJMed 2001;345:1368-77. doi:10.1056/NEJMoa010307
15. Nguyen HB, Rivers EP, Abrahamian FM, et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med 2006; 48:28-54
16. Smith OP, White B, Vaughan D, et al. Use of protein C concentrate, heparin and haemodiafiltration in meningococcus induced purpura fulminans. Lancet 1997;350:1590-3. doi:10.1016/S0140-6736(97)06356-3
17. Veldman A, Fischer D, Wong FY, et al. Human protein C concentrate in the treatment of purpura fulminans: a retrospective analysis of safety and outcome in 94 pediatric patients. Crit Care 2010;14:R156. doi:10.1186/cc9226
18. Public Health Agency of Canada. Canadian immunization guide 2006. 7th ed. Available at: http://www.phac-aspc.gc.ca/ publicat/cig-gci/pdf/cig-gci-2006_e.pdf (accessed July 25, 2011).